JACK(SH:603337)2023-04-11 16:00Financial Performance - The company's operating revenue for 2022 was CNY 550,166.13 million, a decrease of 9.12% compared to CNY 605,360.09 million in 2021[30]. - The net profit attributable to shareholders of the listed company was CNY 49,361.58 million, an increase of 5.84% from CNY 46,638.46 million in the previous year[30]. - The net profit after deducting non-recurring gains and losses was CNY 43,698.04 million, slightly up by 0.18% from CNY 43,618.05 million in 2021[30]. - The net cash flow from operating activities was CNY 88,445.21 million, a significant recovery from a negative CNY 19,792.72 million in 2021[30]. - Basic earnings per share for 2022 were 1.08 yuan, a 2.86% increase compared to 1.05 yuan in 2021[55]. - The weighted average return on net assets decreased by 1.60 percentage points to 13.54% in 2022 from 15.14% in 2021[55]. - The company reported a decrease of 2.04% in basic earnings per share after deducting non-recurring gains and losses, from 0.98 yuan in 2021 to 0.96 yuan in 2022[55]. - Operating cash flow improved significantly from -198 million yuan to 884 million yuan, indicating enhanced operational quality[62]. Assets and Investments - The company's total assets at the end of 2022 were CNY 855,498.81 million, reflecting a 10.58% increase from CNY 773,671.94 million in 2021[30]. - The net assets attributable to shareholders of the listed company increased by 31.43% to CNY 429,050.25 million from CNY 326,438.68 million in 2021[30]. - The total amount of guarantees provided to subsidiaries during the reporting period was CNY 42,297.30 million[145]. - The total amount of guarantees at the end of the reporting period was CNY 29,297.30 million[145]. - The total guarantee amount, including guarantees to subsidiaries, was CNY 29,327.48 million, accounting for 6.84% of the company's net assets[145]. Research and Development - In 2022, the company invested 390 million in R&D, and by the end of 2022, it held 2,601 valid patents[40]. - The company is enhancing its R&D investment and advancing the construction of a large R&D platform[62]. - The company is focusing on joint innovation in R&D to effectively meet user demands and has seen preliminary success in this area[40]. - The company has initiated a comprehensive R&D platform construction to unify pre-research organizations and build a mechatronics integration organization[40]. Market and Sales Performance - The company reported a quarterly revenue breakdown for 2022, with Q1 at CNY 182,089.25 million and Q4 at CNY 110,716.88 million[33]. - The company’s overseas business grew by 28.87% year-on-year, focusing on key markets[63]. - Major customer sales performance increased by 113% year-on-year, driven by the development of key model factories[63]. - The domestic market for industrial sewing equipment saw a decline of 36.1% in sales volume, totaling approximately 230,000 units[67]. - The total production of industrial sewing machines in the industry was estimated at around 6.3 million units, a year-on-year decrease of about 37%[66]. Digital Transformation and Innovation - The company is advancing digital transformation in manufacturing and aims to achieve end-to-end digital integration with suppliers and customers[42]. - The company is implementing a digital transformation in manufacturing systems, focusing on automation and flexible production capabilities[84]. - The company aims to enhance sewing efficiency through research and practice, and has restarted the design of IoT sewing machines, completing the design and development of IoT 2.0[40]. Financial Management - The company has a total of 3 billion in entrusted financial management with an annualized return rate of 3.7% and an actual return of 44.33 million[150]. - The company has a total of 55,018.05 million RMB in financial products, with a remaining balance of 5,044.00 million RMB[178]. - The company has no overdue amounts in its financial products, indicating effective management of its investments[178]. - The company is focused on investing in fixed income assets and financial derivatives approved by regulatory authorities[180]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 7,830[199]. - The number of ordinary shareholders decreased from 8,113 at the end of the previous month to 7,830[199]. - The company issued 36,630,036 new shares approved by the China Securities Regulatory Commission[193]. - The total number of shares increased to 40,930,621 after the issuance[197]. - The company has no preferred shareholders with restored voting rights as of the reporting period end[199]. Corporate Governance and Compliance - The company does not have any significant violations or penalties related to its daily operations[138]. - The company has not identified any changes or progress in previously disclosed related party transactions[141]. - The company confirmed related party transactions for 2021 and estimated the amount for 2022[138].